Asieris Pharmaceuticals
Pharmaceuticals, 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States, 201-500 Employees
Who is ASIERIS PHARMACEUTICALS
Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases. We stri...
Read More
- Headquarters: 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States
- Date Founded: 2010
- Employees: 201-500
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
Industry: Pharmaceuticals
Does something look wrong? Fix it. | View contact records from ASIERIS PHARMACEUTICALS
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Asieris Pharmaceuticals
Answer: Asieris Pharmaceuticals's headquarters are located at 201 King of Prussia Rd, Radnor, Pennsylvania, 19087, United States
Answer: Asieris Pharmaceuticals's official website is https://asieris.com
Answer: Asieris Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Asieris Pharmaceuticals has 201-500 employees
Answer: Asieris Pharmaceuticals is in Pharmaceuticals
Answer: Asieris Pharmaceuticals contact info: Phone number: Website: https://asieris.com
Answer: Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases. We strive to improve human health and help people live a more dignified life. We aim to become a global pharma leader that integrates R&D, manufacturing and commercialization in our areas of focus, as we provide best-in-class integrated diagnosis and treatment solutions for patients in China and worldwide. The company has been developing its proprietary R&D platform and core technologies, exploring new mechanisms of action, and efficiently screening and evaluating drug candidates. With a well-established in-house R&D system and expertise in global drug development, Asieris is committed to launching first-in-class drugs and other innovative products to address huge unmet needs in its areas of focus. Asieris is also enhancing its pipeline for genitourinary diseases via proprietary R&D and strategic partnerships, while closely following cutting-edge technologies and therapeutics. The company strives to discover and identify unmet clinical needs, and adopts a forward-looking approach in product planning and life-cycle management. We aim to establish an outstanding portfolio that covers diagnosis and treatment in a bid to benefit more patients in China and globally.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month